Phase 2b clinical trial of VK0612 in patients with poorly-controlled type 2 diabetes
Latest Information Update: 17 Feb 2015
At a glance
- Drugs VK 0612 (Primary)
- Indications Type 2 diabetes mellitus
- Focus Pharmacodynamics
- Sponsors Viking Therapeutics
Most Recent Events
- 17 Feb 2015 New trial record